AIkido Pharma Inc

(NASDAQ:SPEX)

Latest On AIkido Pharma Inc (SPEX):

Date/Time Type Description Signal Details
2020-11-26 21:37 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 00:56 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:11 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 14:05 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 06:17 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 10:10 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 13:58 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 17:53 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 05:52 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 13:48 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 18:30 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 10:01 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 17:48 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 13:42 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 05:44 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 06:11 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 06:18 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 01:52 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 06:25 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 05:50 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 21:52 ESTFinancialsCompany financials have been released.Neutral
2020-03-25 21:29 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 05:03 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 22:44 ESTFinancialsCompany financials have been released.Neutral
2020-02-22 00:45 ESTFinancialsCompany financials have been released.Neutral
2020-02-18 00:30 ESTFinancialsCompany financials have been released.Neutral
2020-02-13 00:45 ESTFinancialsCompany financials have been released.Neutral
2020-02-07 00:51 ESTFinancialsCompany financials have been released.Neutral
2020-02-06 00:24 ESTFinancialsCompany financials have been released.Neutral
2020-02-01 00:47 ESTFinancialsCompany financials have been released.Neutral
2020-01-29 00:44 ESTFinancialsCompany financials have been released.Neutral
2020-01-28 00:49 ESTFinancialsCompany financials have been released.Neutral
2020-01-25 00:35 ESTFinancialsCompany financials have been released.Neutral
2020-01-16 00:51 ESTFinancialsCompany financials have been released.Neutral
2019-12-22 00:21 ESTFinancialsCompany financials have been released.Neutral
2019-12-17 00:36 ESTFinancialsCompany financials have been released.Neutral
2019-11-29 00:23 ESTFinancialsCompany financials have been released.Neutral
2019-11-28 00:34 ESTFinancialsCompany financials have been released.Neutral
2019-11-27 00:34 ESTFinancialsCompany financials have been released.Neutral
2019-11-16 00:34 ESTFinancialsCompany financials have been released.Neutral
2019-11-15 00:05 ESTFinancialsCompany financials have been released.Neutral
2019-11-14 00:13 ESTFinancialsCompany financials have been released.Neutral
2019-11-07 00:29 ESTFinancialsCompany financials have been released.Neutral
2019-11-01 15:41 ESTNewsHoth Therapeutics up 36%N/A
2019-06-30 01:05 ESTFinancialsCompany financials have been released.Neutral
2019-03-31 01:05 ESTFinancialsCompany financials have been released.Neutral
2018-12-31 00:05 ESTFinancialsCompany financials have been released.Neutral
2018-11-19 00:05 ESTInsider TradeTIM S LEDWICK has directly acquired 10,000 shares and currently holds 30,000 shares.Buy
2018-11-19 00:05 ESTInsider TradeAnthony Hayes has directly acquired 2,000 shares and currently holds 44,183 shares.Buy
2018-11-19 00:05 ESTInsider TradeAnthony Hayes has directly acquired 8,000 shares and currently holds 52,183 shares.Buy

About AIkido Pharma Inc (SPEX):

Spherix Incorporated, a biotechnology development company, focuses on developing small-molecule anti-cancer therapeutics. The company engages in the development of therapeutic drugs for the treatment of various cancers including pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). Its portfolio includes KPC-34 for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and DHA-dFdC drug for chemotherapy treatment and pancreatic cancer. Spherix Incorporated was founded in 1967 and is based in New York, New York.

SPEX Quotes by TradingView

See Advanced Chart

General

  • Name AIkido Pharma Inc
  • Symbol SPEX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorOther
  • IndustryOther
  • Full Time Employees 3
  • Fiscal Year EndDecember
  • Gic SectorIndustrials
  • Gic GroupCommercial & Professional Services
  • Gic IndustryProfessional Services
  • Gic SubIndustryResearch & Consulting Services
  • Web URLwww.spherix.com
View More

Valuation

  • Trailing PE 2.04
  • Price/Sales (Trailing 12 Mt.) 207.4
  • Price/Book (Most Recent Quarter) 2.46
  • Enterprise Value Revenue 2775.66
View More

Financials

  • Most Recent Quarter 0000-00-00
  • Earnings Per Share $0.15
  • Revenue Per Share $0
  • Gross Profit 9000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 22.45 million
  • EBITDA -1900500
  • Analyst Target Price $19
  • Book Value Per Share $2.18
View More

Share Statistics

  • % Held by Insiders <1%
  • Shares Short 1244
  • Shares Short Prior Month 16077
View More

Technicals

  • 52 Week High $0.93
  • 52 Week Low $0.48
  • 50 Day Moving Average 0.57
  • 200 Day Moving Average 1.14
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
View More

AIkido Pharma Inc (SPEX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

AIkido Pharma Inc (SPEX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2018-12-312019-03-12$28000$2.74
2018-09-302018-11-20$N/A-$0.94
2018-06-302018-08-14$N/A-$0.20
2018-03-312018-05-16$N/A-$0.96
2017-12-312018-03-26$284000-$0.67
2017-09-302017-11-14$314000$0.32
2017-06-302017-08-15$311000-$1.59
2017-03-312017-05-16$327000-$0.79
2016-09-302016-11-11$314000-$0.46
2016-06-302016-08-12$177000$39.13
2016-03-312016-05-10$72000-$1.12
2015-12-312016-03-30$31000$8.06
2015-09-302015-11-13$N/A-$6.64
2015-06-302015-08-18$-2000-$113.73
2015-03-312015-05-22$2000-$11.53
2014-09-302014-11-17$20000-$14.80
2014-06-302014-08-18$3000-$55.34
2014-03-312014-05-15$4000-$134.25
2013-09-302013-11-18$2000-$559.52
2013-06-302013-08-19$213-$92.36
2013-03-312013-05-16$6000-$431.85
2012-09-302012-11-20$194301-$297.64
2012-06-302012-08-13$206103-$290.24
2012-03-312012-05-15$209562-$501.57
2011-12-312012-03-28-$799.13
2011-09-302011-11-11$198464-$575.61
2011-06-302011-08-12$186050-$638.90
2011-03-312011-05-20-$155.21
2010-12-312011-03-30-$796.98
2010-09-302010-11-15-$2,014.60
2010-06-302010-08-17-$2,408.37
2010-03-312010-05-21-$2,022.54
2009-12-312010-03-29-$3,705.42
2009-09-302009-11-17-$2,416.06
2009-06-302009-08-17-$1,748.65
2009-03-312009-05-15-$2,324.07
2008-12-312009-03-30$895.85
2008-09-302008-11-14-$1,952.14
2008-06-302008-08-14-$1,351.52
2008-03-312008-05-14-$2,159.04
2007-12-312008-03-04-$2,477.01
2007-09-302007-11-16$5,982.50
2007-06-302007-08-14-$1,977.76
2007-03-312007-05-14-$2,642.87
2006-12-312007-03-30$4,539.69
2006-09-302006-11-13-$11.17
2006-06-302006-08-11$280.72
2006-03-312006-05-12-$663.05
2005-12-312006-03-30-$3,070.04
2005-09-302005-11-10$382.43
2005-06-302005-08-12$308.09
2005-03-312005-05-13-$1,450.34
2004-12-312005-03-29-$3,749.40
2004-09-302004-11-10$396.23
2004-06-302004-08-10$259.30
2004-03-312004-05-13-$757.06
2003-12-312004-03-30-$1,422.69
2003-09-302003-11-14-$163.39
2003-06-302003-08-08-$644.56
2003-03-312003-03-31-$976.57
2002-09-302002-09-30$195.13
2002-06-302002-06-30-$426.89
2002-03-312002-03-31-$1,655.20
2001-09-302001-09-30$2,068.29
2001-06-302001-06-30$416.12
2001-03-312001-03-31-$236.30
2000-09-302000-09-30$663.93
2000-06-302000-06-30$553.72
2000-03-312000-03-31$1,426.07
1999-09-301999-09-30$23.36
1999-06-301999-06-30-$1,444.44
1999-03-311999-03-31-$1,737.46
1998-09-301998-09-30-$650.55
1998-06-301998-06-30$399.95
1998-03-311998-03-31-$90.06

AIkido Pharma Inc (SPEX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2019 Sep 30 2019 Jun 30 2019 Mar 31 2019 Dec 31 2018
Research Development 2.5 million 10000 N/A N/A N/A
Income Before Tax 973000 -3.36 million -644000 -1.15 million 5.5 million
Selling General Administrative 689000 892000 647000 521000 503000
Gross Profit 9000 N/A -175000 -181000 -81000
Ebit -3.18 million -902000 -822000 -702000 -962000
Operating Income -3.18 million -902000 -822000 -702000 -962000
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue 9000 N/A N/A N/A 28000
Cost of Revenue N/A N/A 175000 181000 109000
Total Other Income Expense Net 4.16 million -2.46 million 178000 -447000 6.46 million
Net Income From Continuing Operations 973000 -3.36 million -644000 -1.15 million 5.5 million
Net Income Applicable to Common Shares 973000 -3.36 million -644000 -1.15 million 5.5 million
Cash Flow:
Date Dec 31 2019 Sep 30 2019 Jun 30 2019 Mar 31 2019 Dec 31 2018
Investments 401000 -159000 54000 1.32 million 322000
Change to Liabilities -189000 25000 110000 -10000 62000
Total Cash Flow from Investing Activities 41000 -159000 54000 1.32 million 348000
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities 525000 523000 787000 787000 787000
Change to Operating Activities 59000 43000 -56000 -196000 42000
Change in Cash -222000 -251000 123000 424000 -92000
Total Cash from Operating Activities -788000 -615000 -718000 -896000 -440000
Depreciation N/A N/A N/A N/A 378000
Other Cash Flow from Investing Activities N/A N/A N/A N/A 26000
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities -27000 -79000 N/A N/A N/A
Change to Net Income -1.63 million 2.68 million -128000 459000 -6.42 million
Capital Expenditures 360000 N/A N/A N/A N/A
Balance Sheet:
Date Dec 31 2019 Sep 30 2019 Jun 30 2019 Mar 31 2019 Dec 31 2018
Total Liabailities 750000 852000 845000 982000 1.15 million
Total Stockholder Equity 10.53 million 8.58 million 11.21 million 10.96 million 12.1 million
Other Current Liabilities N/A 1000 8000 212000 82000
Total Assets 11.28 million 9.43 million 12.05 million 11.94 million 13.25 million
Common Stock N/A N/A N/A N/A 1000
Other Current Assets N/A N/A 106000 165000 188000
Retained Earnings -144.27 million -145.24 million -141.88 million -141.23 million -140.08 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets N/A N/A N/A N/A N/A
Cash 91000 313000 564000 446000 17000
Total Current Liabilities 750000 852000 845000 982000 1.15 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment N/A N/A N/A N/A 1000
Total Current Assets 1.13 million 1.3 million 1.49 million 1.87 million 2.91 million
Long Term Investments 10.15 million 8.13 million 10.57 million 10.07 million 10.35 million
Net Tangible Assets 10.53 million 8.58 million 11.21 million 10.96 million 12.1 million
Short Term Investments 857000 938000 817000 1.26 million 2.7 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 68000 257000 232000 122000 32000

AIkido Pharma Inc (SPEX) Chart:

AIkido Pharma Inc (SPEX) News:

Below you will find a list of latest news for AIkido Pharma Inc (SPEX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

AIkido Pharma Inc (SPEX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

AIkido Pharma Inc (SPEX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2018-01-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/12239/000000000018001743/0000000000-18-001743-index.htm
2019-07-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/12239/000000000019010686/0000000000-19-010686-index.htm
2019-07-25UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/12239/000000000019011548/0000000000-19-011548-index.htm
2020-02-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/12239/000000000020001269/0000000000-20-001269-index.htm
2020-03-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/12239/000091957420002437/0000919574-20-002437-index.htm
2020-02-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/12239/000110465920026927/0001104659-20-026927-index.htm
2020-02-285Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/12239/000110465920026941/0001104659-20-026941-index.htm
2020-04-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/12239/000110465920050835/0001104659-20-050835-index.htm
2019-06-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/12239/000121390019010256/0001213900-19-010256-index.htm
2019-06-078-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390019010258/0001213900-19-010258-index.htm
2019-06-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/12239/000121390019010992/0001213900-19-010992-index.htm
2019-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390019010999/0001213900-19-010999-index.htm
2019-06-19DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/12239/000121390019011000/0001213900-19-011000-index.htm
2019-07-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/12239/000121390019013493/0001213900-19-013493-index.htm
2019-07-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/12239/000121390019013495/0001213900-19-013495-index.htm
2019-08-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/12239/000121390019015200/0001213900-19-015200-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390019015209/0001213900-19-015209-index.htm
2019-08-12DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/12239/000121390019015210/0001213900-19-015210-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/12239/000121390019015803/0001213900-19-015803-index.htm
2019-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390019016336/0001213900-19-016336-index.htm
2019-08-19DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/12239/000121390019016338/0001213900-19-016338-index.htm
2019-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390019016609/0001213900-19-016609-index.htm
2019-08-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/12239/000121390019016610/0001213900-19-016610-index.htm
2019-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390019017374/0001213900-19-017374-index.htm
2019-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390019020194/0001213900-19-020194-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/12239/000121390019022956/0001213900-19-022956-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390019025719/0001213900-19-025719-index.htm
2020-01-14SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/12239/000121390020000986/0001213900-20-000986-index.htm
2020-01-31S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/12239/000121390020002270/0001213900-20-002270-index.htm
2020-02-0310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/12239/000121390020002309/0001213900-20-002309-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390020004633/0001213900-20-004633-index.htm
2020-02-27S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/12239/000121390020004859/0001213900-20-004859-index.htm
2020-02-28S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/12239/000121390020005069/0001213900-20-005069-index.htm
2020-02-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/12239/000121390020005072/0001213900-20-005072-index.htm
2020-03-02CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/12239/000121390020005166/0001213900-20-005166-index.htm
2020-03-02CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/12239/000121390020005168/0001213900-20-005168-index.htm
2020-03-04424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/12239/000121390020005413/0001213900-20-005413-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390020005690/0001213900-20-005690-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390020005756/0001213900-20-005756-index.htm
2020-03-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/12239/000121390020005832/0001213900-20-005832-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390020005904/0001213900-20-005904-index.htm
2020-03-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/12239/000121390020006049/0001213900-20-006049-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390020007335/0001213900-20-007335-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390020007481/0001213900-20-007481-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390020007482/0001213900-20-007482-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390020007744/0001213900-20-007744-index.htm
2020-04-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/12239/000121390020009236/0001213900-20-009236-index.htm
2020-04-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390020009243/0001213900-20-009243-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390020009553/0001213900-20-009553-index.htm
2020-04-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/12239/000121390020009937/0001213900-20-009937-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000121390020010782/0001213900-20-010782-index.htm
2020-05-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/12239/000121390020011695/0001213900-20-011695-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/12239/000121390020012254/0001213900-20-012254-index.htm
2020-05-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/12239/000121390020012985/0001213900-20-012985-index.htm
2020-05-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/12239/000121390020012987/0001213900-20-012987-index.htm
2020-04-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/12239/000138713120004085/0001387131-20-004085-index.htm
2020-04-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/12239/000153561020000087/0001535610-20-000087-index.htm
2017-06-128-A12G/ARegistration of securities [Section 12(g)]https://www.sec.gov/Archives/edgar/data/12239/000161577417003104/0001615774-17-003104-index.htm
2017-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577417003253/0001615774-17-003253-index.htm
2017-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577417003472/0001615774-17-003472-index.htm
2017-07-05S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/12239/000161577417003480/0001615774-17-003480-index.htm
2017-07-17S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/12239/000161577417003655/0001615774-17-003655-index.htm
2017-07-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/12239/000161577417003661/0001615774-17-003661-index.htm
2017-07-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/12239/000161577417003663/0001615774-17-003663-index.htm
2017-07-18S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/12239/000161577417003694/0001615774-17-003694-index.htm
2017-07-18S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/12239/000161577417003701/0001615774-17-003701-index.htm
2017-07-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/12239/000161577417003702/0001615774-17-003702-index.htm
2017-07-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/12239/000161577417003703/0001615774-17-003703-index.htm
2017-07-20424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/12239/000161577417003742/0001615774-17-003742-index.htm
2017-07-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577417003768/0001615774-17-003768-index.htm
2017-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/12239/000161577417004286/0001615774-17-004286-index.htm
2017-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577417005899/0001615774-17-005899-index.htm
2017-11-07DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/12239/000161577417006278/0001615774-17-006278-index.htm
2017-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/12239/000161577417006703/0001615774-17-006703-index.htm
2017-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577417007311/0001615774-17-007311-index.htm
2018-01-09S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/12239/000161577418000227/0001615774-18-000227-index.htm
2018-01-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/12239/000161577418000400/0001615774-18-000400-index.htm
2018-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/12239/000161577418001338/0001615774-18-001338-index.htm
2018-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/12239/000161577418001339/0001615774-18-001339-index.htm
2018-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/12239/000161577418001340/0001615774-18-001340-index.htm
2018-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577418001879/0001615774-18-001879-index.htm
2018-03-14425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/12239/000161577418001880/0001615774-18-001880-index.htm
2018-03-15424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/12239/000161577418001890/0001615774-18-001890-index.htm
2018-03-16424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/12239/000161577418001950/0001615774-18-001950-index.htm
2018-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577418001979/0001615774-18-001979-index.htm
2018-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577418002153/0001615774-18-002153-index.htm
2018-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/12239/000161577418002232/0001615774-18-002232-index.htm
2018-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577418002483/0001615774-18-002483-index.htm
2018-04-09425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/12239/000161577418002484/0001615774-18-002484-index.htm
2018-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577418003380/0001615774-18-003380-index.htm
2018-05-07DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/12239/000161577418003381/0001615774-18-003381-index.htm
2018-05-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/12239/000161577418003421/0001615774-18-003421-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/12239/000161577418003423/0001615774-18-003423-index.htm
2018-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577418003514/0001615774-18-003514-index.htm
2018-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/12239/000161577418003870/0001615774-18-003870-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/12239/000161577418008063/0001615774-18-008063-index.htm
2018-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577418010961/0001615774-18-010961-index.htm
2018-10-16425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/12239/000161577418010962/0001615774-18-010962-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/12239/000161577418012680/0001615774-18-012680-index.htm
2018-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/12239/000161577418013017/0001615774-18-013017-index.htm
2018-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/12239/000161577418013019/0001615774-18-013019-index.htm
2018-11-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577418013505/0001615774-18-013505-index.htm
2019-01-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577419000715/0001615774-19-000715-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577419001998/0001615774-19-001998-index.htm
2019-02-28PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/12239/000161577419003246/0001615774-19-003246-index.htm
2019-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/12239/000161577419003916/0001615774-19-003916-index.htm
2019-03-12DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/12239/000161577419003918/0001615774-19-003918-index.htm
2019-03-13DEFR14ARevised definitive proxy soliciting materialshttps://www.sec.gov/Archives/edgar/data/12239/000161577419004013/0001615774-19-004013-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577419005837/0001615774-19-005837-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577419007388/0001615774-19-007388-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/12239/000161577419007947/0001615774-19-007947-index.htm
2019-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577419007976/0001615774-19-007976-index.htm
2019-05-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/12239/000161577419007977/0001615774-19-007977-index.htm
2019-05-31424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/12239/000161577419009013/0001615774-19-009013-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/12239/000161577419009017/0001615774-19-009017-index.htm
2017-07-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/12239/999999999517001844/9999999995-17-001844-index.htm
2018-01-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/12239/999999999518000173/9999999995-18-000173-index.htm
2020-03-03EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/12239/999999999520000458/9999999995-20-000458-index.htm

AIkido Pharma Inc (SPEX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of AIkido Pharma Inc (SPEX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: < 1%
Institutional Ownership: < 1%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-02-16Eric WeisblumDirectorBuy20,000.0020,000.00https://www.sec.gov/Archives/edgar/data/12239/000161577418001339/0001615774-18-001339-index.htm
2018-02-16TIM S LEDWICKDirectorBuy20,000.0020,000.00https://www.sec.gov/Archives/edgar/data/12239/000161577418001340/0001615774-18-001340-index.htm
2018-02-16Robert J VanderZandenDirectorBuy20,000.0021,007.00https://www.sec.gov/Archives/edgar/data/12239/000161577418001338/0001615774-18-001338-index.htm
2018-11-19TIM S LEDWICKDirectorBuy10,000.000.909,000.0030,000.00https://www.sec.gov/Archives/edgar/data/12239/000161577418013019/0001615774-18-013019-index.htm
2018-11-19Anthony HayesChief Executive OfficerBuy2,000.000.901,800.0044,183.00https://www.sec.gov/Archives/edgar/data/12239/000161577418013017/0001615774-18-013017-index.htm
2018-11-19Anthony HayesChief Executive OfficerBuy8,000.000.887,040.0052,183.00https://www.sec.gov/Archives/edgar/data/12239/000161577418013017/0001615774-18-013017-index.htm